Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Read ArticleRisk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex
Read ArticleA Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
Read ArticleObservational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines
Read ArticleWorse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19
Read ArticleAssessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System
Read ArticleThe presence of serum anti-SARS-CoV-2 IgA appears toprotect primary health care workers from COVID-19
Read ArticlePersistent Cardiac MRI Findings in a Cohort of Adolescents with post COVID-19 mRNA vaccine myopericarditis
Read ArticleMyocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination
Read ArticleAutopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose
Read ArticleRisk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis
Read ArticleMyocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Read ArticleA report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination
Read ArticleMyocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
Read ArticleAssociation of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Read ArticleAutopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose
Read ArticleEstablishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
Read ArticleAssessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
Read ArticleCommunity transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Read ArticleCOVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines
Read ArticleLong-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
Read ArticleLongitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report
Read ArticleFACT SHEET FOR RECIPIENTS AND CAREGIVERS EMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER
Read ArticlePandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
Read Article(STUDY) Why so many vaccinated people are getting sick: Antibody Dependent Enhancement (ADE)
Read ArticlePEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
Read ArticleAntigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Read ArticleChildren develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
Read ArticleThe SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
Read ArticlemRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
Read ArticleVaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Read ArticleAntibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
Read ArticlePrior COVID-19 protects against reinfection, even in the absence of detectable antibodies
Read ArticlePolyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTechmRNA COVID‐19 vaccine
Read ArticleA Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
Read ArticleImmunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Read ArticleHigh-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
Read ArticleCovid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Read ArticlePost COVID-19 vaccination neuromyelitis optical spectrum disorder: Case report & MRI findings
Read ArticleComparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
Read ArticleNeuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine
Read ArticleCirculating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Read ArticlePrior COVID-19 protects against reinfection, even in the absence of detectable antibodies
Read ArticleNonarteritic Anterior Ischemic Optic Neuropathy following COVID-19 Vaccination: Consequence or Coincidence
Read ArticleLong-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response
Read ArticleAssociations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar
Read ArticleIncreased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individual
Read ArticleNegligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees
Read ArticleAlkylative damage of mRNA leads to ribosome stalling and rescue by trans translation in bacteria
Read ArticlePrevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19
Read ArticleNegligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees
Read ArticleU.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses
Read ArticleInfection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
Read ArticleEquivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Read ArticleSARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Read ArticleDifferential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals
Read ArticlemRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status
Read Article